Oncotelic Therapeutics (OTLC) Return on Equity [ROE] (2011 - 2026)
Oncotelic Therapeutics (OTLC) posted Return on Equity [ROE] of 94.72% for Q2 2026, up 152.06 percentage points from -57.35% a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Return on Equity [ROE] (2011 - 2026) Analysis & Trends
For FY2025, Oncotelic Therapeutics' Return on Equity [ROE] came in at 184.30%, up 234.38 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a five-year change of +252.18 percentage points (FY2020 to FY2025).
- In prior years, Oncotelic Therapeutics' Return on Equity [ROE] was -50.08% in FY2024 (+3.20 pp), -53.28% in FY2023 (-87.47 pp), 34.20% in FY2022 (+136.11 pp) and -101.92% in FY2021 (-34.04 pp).
- Quarterly Return on Equity [ROE] has run from a low of -172.43% in Q1 2022 to a high of 183.23% in Q4 2025 over five years.
- On a year-over-year basis, Return on Equity [ROE] increased in six of the last seven quarters, with an average year-over-year change of +64.33 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2025, with a gain of 244.47 percentage points; the weakest was Q3 2023, with a drop of 139.61 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | - |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 31.52% |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 4.97% |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | 94.72% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 94.72% |
| Dec 31, 2025 | 183.23% |
| Sep 30, 2025 | -23.38% |
| Jun 30, 2025 | -57.35% |
| Mar 31, 2025 | -63.69% |
| Dec 31, 2024 | -61.24% |
| Sep 30, 2024 | -50.07% |
| Jun 30, 2024 | -13.21% |
| Mar 31, 2024 | -70.65% |
| Dec 31, 2023 | -69.26% |
| Sep 30, 2023 | -106.28% |
| Jun 30, 2023 | -89.94% |
| Mar 31, 2023 | 48.67% |
| Dec 31, 2022 | 21.64% |
| Sep 30, 2022 | 33.33% |
| Jun 30, 2022 | 46.10% |
| Mar 31, 2022 | -172.43% |
| Dec 31, 2021 | -127.11% |
| Sep 30, 2021 | -138.59% |
| Jun 30, 2021 | -122.52% |
API Access
Oncotelic Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();